A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1855-1859

  Chinh, Nguyen Tran ^a   Parry, Christopher M ^b   Ly, Nguyen Thi ^a   Ha, Huynh Duy ^b   Thong, Mai Xuan ^b   Diep, To Song ^b   Wain, John ^b   White, Nicholas J ^b   Farrar, Jeremy J ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b Centre for Tropical Diseases Vietnam   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; NALIDIXIC ACID; OFLOXACIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FECES CULTURE; FEMALE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SALMONELLA ENTERICA; STRAIN DIFFERENCE; TYPHOID FEVER; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; NALIDIXIC ACID; OFLOXACIN; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; TYPHOID FEVER;

EID: 0343526371     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1855-1859.2000     Document Type: Article

References (29)

1. Brown, N. M., M. R. Millar, J. A. Frost, and B. Rowe. 1994. Ciprofloxacin resistance in Salmonella paratyphi A. J. Antimicrob. Chemother. 33:1258-1259.
2. Brown, J. C., P. M. A. Shanahan, M. V. Jesudason, C. J. Thomson, and S. G. B. Aymes. 1996. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J. Antimicrob. Chemother. 37:891-900.
3. Butler, T., and A. E. Girard. 1993. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. J. Antimicrob. Chemother. 31:313-319.
4. Butler, T., C. Sridhar, M. Daga, K. Kani, R. Pandit, R. Khakhria, C. Potkar, and R. Johnson. 1999. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J. Antimicrob. Chemother. 44:243-250.
5. Chinh, N. T., T. Solomon, M. X. Thong, N. T. Ly, N. T. T. Hoa, J. Wain, T. S. Diep, M. D. Smith, N. P. J. Day, L. T. Phi, C. M. Parry, and N. J. White. 1997. Short course of ofloxacin for the treatment of enteric fever. Trans. R. Soc. Trop. Med. Hyg. 91:347-349.
6. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
7. Girgis, N. I., T. Butler, R. W. Frenck, Y. Sultan, F. M. Brown, D. Tribble, and R. Khakhria. 1999. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob. Agents Chemother. 43:1441-1444.
8. Jesudason, M. V., B. Malathy, and T. J. John. 1996. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J. Med. Res. 103:247-249.
9. Luke, D. R., G. Foulds, S. F. Cohen, and B. Levy. 1996. Safety, toleration and pharmacokinetics of intravenous azithromycin. Antimicrob. Agents Chemother. 40:2577-2581.
10. Metchock, B. 1990. In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi. J. Antimicrob. Chemother. 25(Suppl. A):29-31.
11. Mitchell, D. H. 1997. Ciprofloxacin-resistant Salmonella typhi: an emerging problem. Med. J. Aust. 167:172.
12. Murdoch, D. A., N. A. Banatvala, A. Bone, B. I. Shoismatulloev, L. R. Ward, and E. J. Threlfall. 1998. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 351:339.
13. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial sensitivity testing: eighth informational supplement, vol. 18. M100-S8. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Panteix, G., B. Guillaumond, R. Harf, A. Desbos, V. Sapin, M. Leclerq, and M. Perrin-Fayolle. 1993. In vitro concentration of azithromycin in human phagocytic cells. J. Antimicrob. Chemother. 31(Suppl. E):1-4.
17. Parry, C., J. Wain, N. T. Chinh, H. Vinh, and J. J. Farrar. 1998. Quinolone-resistant Salmonella typhi in Vietnam. Lancet 351:1289.
18. Rakita, R. M., K. Jaques-Palaz, and B. E. Murray. 1994. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents Chemother. 38:1915-1921.
19. Rowe, B., E. J. Threlfall, and L. R. Ward. 1995. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 346:1302.
20. Rowe, B., L. R. Ward, and E. J. Threlfall. 1997. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin. Infect. Dis. 24(Suppl. 1):S106-S109.
21. Sana, S. K., S. Y. Talukder, M. Islam, and S. Saha. 1999. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr. Infect. Dis. J. 18:387.
22. Smith, M. D., N. M. D. Duong, N. T. T. Hoa, J. Wain, H. D. Ha, T. S. Diep, N. P. J. Day, T. T. Hien, and N. J. White. 1994. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob. Agents Chemother. 38:1716-1720.
23. Threlfall, E. J., L. R. Ward, J. A. Skinner, H. R. Smith, and S. Lacey. 1999. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 353: 1590-1591.
24. Tribble, D., N. Girgis, N. Habib, and T. Butler. 1995. Efficacy of azithromycin for typhoid fever. Clin. Infect. Dis. 21:1045-1046.
25. Umasanker, S., R. A. Wall, and J. Berger. 1992. A case of ciprofloxacin-resistant typhoid fever. CDR Rev. 2:R139-R140.
26. Wain, J., N. T. T. Hoa, N. T. Chinh, H. Vinh, M. J. Everett, T. S. Diep, N. P. J. Day, T. Solomon, N. J. White, and C. M. Parry. 1997. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25:1404-1410.
27. Wain, J., T. S. Diep, V. A. Ho, A. M. Walsh, N. T. T. Hoa, C. M. Parry, and N. J. White. 1998. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility and antibiotic resistance. J. Clin. Microbiol. 36:1683-1687.
28. Wallace, M. R., A. A. Yousif, N. F. Habib, and D. R. Tribble. 1994. Azithromycin and typhoid. Lancet 343:1497-1498.
29. White, N. J., and C. M. Parry. 1996. The treatment of typhoid fever. Curr. Opin. Infect. Dis. 9:298-302.